+

WO2003058198A3 - Human breast cancer biomarkers - Google Patents

Human breast cancer biomarkers Download PDF

Info

Publication number
WO2003058198A3
WO2003058198A3 PCT/US2002/041614 US0241614W WO03058198A3 WO 2003058198 A3 WO2003058198 A3 WO 2003058198A3 US 0241614 W US0241614 W US 0241614W WO 03058198 A3 WO03058198 A3 WO 03058198A3
Authority
WO
WIPO (PCT)
Prior art keywords
breast cancer
human breast
cancer biomarkers
markers
biomarkers
Prior art date
Application number
PCT/US2002/041614
Other languages
French (fr)
Other versions
WO2003058198A2 (en
Inventor
Tai-Tung Yip
Christine Yip
Original Assignee
Ciphergen Biosystems Inc
Tai-Tung Yip
Christine Yip
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciphergen Biosystems Inc, Tai-Tung Yip, Christine Yip filed Critical Ciphergen Biosystems Inc
Priority to AU2002360815A priority Critical patent/AU2002360815A1/en
Publication of WO2003058198A2 publication Critical patent/WO2003058198A2/en
Publication of WO2003058198A3 publication Critical patent/WO2003058198A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

The invention provides markers, methods and kits that can be used as an aid for breast cancer diagnosis using markers that are differentially present in the samples of breast cancer patients and a control (e.g., women in whom breast cancer is undetectable).
PCT/US2002/041614 2001-12-27 2002-12-23 Human breast cancer biomarkers WO2003058198A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002360815A AU2002360815A1 (en) 2001-12-27 2002-12-23 Human breast cancer biomarkers

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34390701P 2001-12-27 2001-12-27
US60/343,907 2001-12-27

Publications (2)

Publication Number Publication Date
WO2003058198A2 WO2003058198A2 (en) 2003-07-17
WO2003058198A3 true WO2003058198A3 (en) 2004-10-14

Family

ID=23348190

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/041614 WO2003058198A2 (en) 2001-12-27 2002-12-23 Human breast cancer biomarkers

Country Status (2)

Country Link
AU (1) AU2002360815A1 (en)
WO (1) WO2003058198A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041453B2 (en) 2002-08-22 2006-05-09 Bioarray Solutions Ltd. Molecular constructs and methods of use for detection of biochemical reactions
US20100173788A1 (en) * 2005-06-21 2010-07-08 Vermillion, Inc. Biomarkers for breast cancer
WO2012040447A2 (en) * 2010-09-22 2012-03-29 The Board Of Trustees Of The University Of Arkansas Biomarkers for determining breast cancer bone metastasis
IL290257B2 (en) 2019-08-05 2023-11-01 Seer Inc Systems and methods for sample preparation, data generation and corona protein analysis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PAWELETZ ET AL: "Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer", DISEASE MARKERS, vol. 17, no. 4, 2001, pages 301 - 307, XP002972750 *
WATKINS ET AL: "Surface enhanced laser desorption-ionization (SELDI) mass spectroscopy in the discovery of serum markers for breast cancer", TUMOR BIOLOGY, vol. 21, no. SUPPL. 1, September 2000 (2000-09-01), pages 35, XP001001193 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers

Also Published As

Publication number Publication date
WO2003058198A2 (en) 2003-07-17
AU2002360815A1 (en) 2003-07-24
AU2002360815A8 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
AU4085097A (en) Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
AU2004205878A8 (en) Gene expression markers for breast cancer prognosis
DE69907153D1 (en) CANCER TREATMENT
PT1157041E (en) ANTIBODIES FOR CANCER THERAPY AND DIAGNOSIS
WO2004060302A3 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
AU2002323120A1 (en) Periostin-based diagnostic assays
AU7868300A (en) Prostate cancer marker proteins
AU2002324451A1 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
WO2002023200A3 (en) Human breast cancer biomarkers
WO2005070456A3 (en) Diagnosing and treating female reproductive tract or chilhood cancer with pmsa antibodies
AU2003217397A1 (en) Claudins, markers for diagnosis, prognosis and therapy of breast, bone, brain cancer
WO2001062784A3 (en) Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer
AU2001240909A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
WO2003058198A3 (en) Human breast cancer biomarkers
WO2003084384A3 (en) Diagnosis of flavivirus infection
WO2003031942A8 (en) Reagents and methods useful for detecting diseases of the breast
WO2005030266A3 (en) Optical imaging of colorectal cancer
WO2001092877A3 (en) Method of identifying and/or isolating stem cells
WO2002027329A3 (en) Biomarkers of transitional cell carcinoma of the bladder
AU2001233912A1 (en) Diagnosis of breast cancer using bcmp-81 as marker
AU2002306568A1 (en) Forms of prostate specific antigens and methods for their detection
AU2002365104A1 (en) Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof
AU2002348101A1 (en) Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
WO2003028539A3 (en) Materials and methods for the diagnosis of pediatric tumors
AU2001257313A1 (en) Method and apparatus for the detection and diagnosis of cancer, specifically breast cancer using diffusion mri

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载